Ladenburg Thalmann Assumes Immunic Inc. (IMUX) at Buy Oct 16, 2025 06:40AM
Immunic Inc. (IMUX) Announces $240M Private Placement Jan 5, 2024 06:31AM
Immunic, Inc. Announces Private Placement of up to $240 Million Jan 5, 2024 06:30AM
Immunic, Inc. to Participate in Investor Conferences in September Sep 1, 2022 06:30AM
Immunic Inc. (IMUX) Prices 4.5M Share Offering at $10/sh Jul 15, 2021 09:19AM


Jul 15, 2021 09:19AM Immunic, Inc. Announces Pricing of $45 Million Public Offering of Common Stock
Jun 28, 2021 06:30AM Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in July
Aug 10, 2020 06:30AM Immunic, Inc. Announces Closing of $103.5 Million Public Offering, including Full Exercise of Underwriters' Option to Purchase Additional Shares
Aug 5, 2020 05:55AM Immunic Inc. (IMUX) Prices 5M Share Common Offering at $18/Sh
Aug 4, 2020 08:29PM Immunic, Inc. Announces Pricing of $90.0 Million Public Offering of Common Stock
Aug 3, 2020 04:54PM Immunic Inc. (IMUX) Announces Proposed Public Offering of 5 Million Shares of Common Stock
Aug 3, 2020 04:15PM Immunic, Inc. Announces Proposed Public Offering of 5 Million Shares of Common Stock
Jun 10, 2020 09:18AM Immunic Inc. (IMUX) Prices 2.18M Share Common Stock Offering at $11.40/Each
Jun 10, 2020 09:16AM Immunic, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
Sep 3, 2019 06:30AM Immunic, Inc. to Participate in Scientific and Investor Conferences in September
Apr 23, 2019 06:59AM UPDATE: Ladenburg Thalmann Starts Immunic Inc. (IMUX) at Buy
Apr 12, 2019 01:01PM Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases